Normal triglyceride levels and coronary artery disease events: The Baltimore Coronary Observational Long-Term Study

Journal of the American College of Cardiology

Volumn 31, Issue 6, 1998, Pages 1252-1257

  Miller, Michael ^a   Seidler, Alexander ^a   Moalemi, Azita ^a   Pearson, Thomas A ^b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ARTICLE; COHORT ANALYSIS; CORONARY ARTERY DISEASE; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OBSERVATION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0032080923     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00083-7     Document Type: Article

References (48)

1. 1. Albrink MJ, Man EB. Serum triglycerides in coronary artery disease. Arch Inten Med 1959;103:4-8.
2. 2. Brown DF, Kinch SH, Doyle JT. Serum triglycerides in health and in ischemic heart disease. N Engl J Med 1965;273:947-52.
3. 3. Hulley SB, Rosenman RH, Bawol RD, Brand RJ. Epidemiology as a guide to clinical decisions: the association between triglyceride and coronary heart disease. N Engl J Med 1980;302:1383-89.
4. 4. Rapp JH, Lespine A, Hamilton RL, et al. Triglyceride-rich lipoproteins isolated by selected-affinity anti-apolipoprotein B immunosorption from human atherosclerotic plaque. Arterioscler Thromb 1994;14:1767-74.
5. 5. Drexel H, Amann FW, Beran J, et al. Plasma triglycerides and three lipoprotein cholesterol fractions are independent predictors of the extent of coronary atherosclerosis. Circulation 1994;90:2230-35.
6. 6. Phillips NR, Waters D, Havel RJ. Plasma lipoproteins and progression of coronary artery disease evaluated by angiography and clinical events. Circulation 1993;88:2762-70.
7. 7. Hodis HN, Mack WJ, Azen SP, et al. Triglyceride-and cholesterol-rich lipoproteins have a differential effect on mild/moderate and severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of lovastatin. Circulation 1994;90:42-9.
8. 8. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med 1992;326:242-50.
9. 9. Second report of the expert panel on detection, evaluation, and treatment of high blood cholesterol in adults. National Cholesterol Education Program. Bethesda (MD): National Institutes of Health; 1993 Report No.: NIH 93-3095.
10. 10. Stamler J, Wentworth D, Neaton JD. Is the relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the Multiple Risk Factor Intervention Trial (MRFIT). JAMA 1986;256: 2823-8.
11. 11. NIH Consensus Development Panel on Triglyceride, High-Density Lipoprotein, and Coronary Heart Disease. JAMA 1993;269:505-10.
12. 12. The lipid research clinics population studies data book, vol. 1: the prevalence study. Bethesda (MD): US Department of Health and Human Services, Public Health Service; 1980 Report No. USDHHS (NIH) 80-1527.
13. 13. Pearson TA. Risk factors for arteriographically defined CAD [dissertation]. Baltimore (MD): John Hopkins University, 1983.
14. 14. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
15. 15. Austen WG, Edwards JE, Frye RL, et al. AHA Committee Report: a reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975;51: 7-39.
16. 16. Dodds C, Mills GL. Influence of myocardial infarction on plasma lipoprotein concentration. Lancet 1959;1:1160-3.
17. 17. Huttunen JK, Ehnholm C, Kekki M, Nikkila EA. Postheparin plasma lipoprotein lipase in normal subjects and in patients with hypertriglyceridemia: correlations to sex, age, and various parameters of triglyceride metabolism. Clin Sci Mol Med 1976;50:249-60.
18. 18. The International Classification of Diseases, Revision 9, Clinical Modification: ICD-9-CM. 3rd ed. Washington (DC): Government Printing Office, 1989 (DHHS publication no. 89-1260).
19. 19. World Health Organization. IHD registers: report of the Fifth Working Group. Copenhagen: World Health Organization, 1971.
20. 20. Kahn HA, Sempos CT. Statistical Methods in Epidemiology. New York: Oxford University Press, 1989:168-206.
21. 21. Ames RP. The effects of antihypertensive drugs on serum lipids and lipoproteins. Drugs 1986;32:260-78.
22. 22. Ulvenstam G, Aberg A, Bergstrand R, et al. Long term prognosis after myocardial infarction in men with diabetes. Diabetes 1985;34:7870-92.
23. 23. Gordon DJ, Probstfield JL, Garrison RJ, et al. High density lipoprotein cholesterol and coronary heart disease - four prospective American studies. Circulation 1989;79:8-15.
24. 24. Benlian P, De Gennes JL, Foubert L, Zhang H, Gagnè SE, Hayden M. Premature atherosclerosis in patients with familial chylomicronemia caused by mutations in the lipoprotein lipase gene. N Engl J Med 1996;335:848-54.
25. 25. Farmer RG, Winkelman EI, Brown HB, Lewis HA. Hyperlipoproteinemia and pancreatitis. Am J Med 1973;54:161-5.
26. 26. Gianturco SH, Bradley WA, Gotto AM, Morrisett JD, Peavy DL. Hypertriglyceridemic very low density lipoproteins induce triglyceride synthesis and accumulation in mouse peritoneal macrophages. J Clin Invest 1982;70:168-78.
27. 27. Jemaa R, Fumeron F, Poirier O, et al. Lipoprotein lipase gene polymorphisms: associations with myocardial infarction and lipoprotein levels, the ECTIM study. J Lipid Res 1995;36:2141-6.
28. 28. Reymer PWA, Gagne E, Groenemeyer BE. A lipoprotein lipase mutation (Asn291Ser) is associated with reduced HDL cholesterol levels in premature atherosclerosis. Nature Genet 1995;10:28-34.
29. 29. Wang XL, McCredie RM, Wilcken DEL. Common DNA polymorphisms at the lipoprotein lipase gene: association with severity of coronary artery disease and diabetes. Circulation 1996;93:1339-45.
30. 30. McPherson R, Mann CJ, Tall AR, et al. Plasma concentrations of cholesteryl ester transfer protein in hyperlipoproteinemia: relation to cholesteryl ester transfer protein activity and other lipoprotein variables. Arterioscler Thromb 1991;11:797-804.
31. 31. Austin MA, King M-C, Vranizan KM, Krauss RM. Atherogenic lipoprotein phenotype: a proposed genetic marker for coronary heart disease risk. Circulation 1990;82:495-506.
32. 32. Horowitz BS, Goldberg IJ, Merab J, et al. Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol. J Clin Invest 1993;91: 1743-52.
33. 33. Zilversmit DB. Atherogenic nature of triglycerides, postprandial lipidemia and triglyceride-rich remnant lipoproteins. Clin Chem 1995;41:153-8.
34. 34. Patsch JR, Miesenböck G, Hopferwieser T, et al. Relation of triglyceride metabolism and coronary artery disease: studies in the postprandial state. Arterioscler Thromb 1992;12:1336-45.
35. 35. Genest J, Sniderman A, Cianflone K, et al Hyperapobetalipoproteinemia: plasma lipoprotein responses to oral fat load. Arteriosclerosis 1986;8:297-304.
36. 36. Hypertriglyceridaemia and vascular risk: report of a meeting of physicians and scientists, University College London Medical School. Lancet 1993;342: 781-7.
37. 37. Castelli WP. Cholesterol and lipids in the risk of coronary artery disease: the Framingham Heart Study. Can J Cardiol 1988;4 Suppl A:5a-10a.
38. 38. Assman G, Schulte H. Relation of high-density lipoprotein cholesterol and triglycerides to incidence of atherosclerotic coronary artery disease (the PROCAM) experience. Am J Cardiol 1992;70:733-7.
39. 39. Fontbonne A, Eschwege E, Cambien F, et al. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes: results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 1989;32:300-4.
40. 40. Manninen V, Tenkanen L, Koskinen P, et al. Joint effects of serum triglyceride and LDL cholesterol and HDL cholesterol concentrations on coronary heart disease risk in the Helsinki Heart Study: implications for treatment. Circulation 1992;85:37-45.
41. 41. Ericsson C-G, Hamsten A, Nilsson J, Grip L, Svane B, Faire U. Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients. Lancet 1996;347:849-53.
42. 42. Frick MH, Syvänne M, Nieminen MS, et al. Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Circulation 1997;96:2137-43.
43. 43. Rubins HB, Robins SJ, Collins D, et al. The Veterans Affairs high-density lipoprotein intervention trial: baseline characteristics of normocholesterolemic men with coronary artery disease and low levels of high-density lipoprotein cholesterol. Am J Cardiol 1996;78:572-5.
44. 44. Kwiterovich PO, Coresh J, Bachorik PS. Prevalence of hyperapobetalipoproteinemia and other lipoprotein phenotypes in men and women with coronary artery disease. Am J Cardiol 1993;71:631-9.
45. 45. Miller M, Bachorik PS, Cloey TA. Normal variation of plasma lipoproteins: postural effects on plasma concentrations of lipids, lipoproteins, and apolipoproteins. Clin Chem 1992;38:569-74.
46. 46. Miller M. Triglycerides. In: Miller M, Vogel RA, editors. The Practice of Coronary Disease Prevention. Baltimore (MD): Williams & Wilkins, 1996: 86-103.
47. 47. Gaziano JM, Hennekens CH, O'Donnell CJ, Breslow JL, Buring JE. Fasting triglycerides, high-density lipoprotein, and risk of myocardial infarction. Circulation 1997;96:2520-5.
48. 48. Hokanson JE, Austin MA. Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies. J Cardiovasc Risk 1996;3:213-9.